Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

8.10
Delayed Data
As of 3:19pm ET
 -0.06 / -0.74%
Today’s Change
5.49
Today|||52-Week Range
9.54
+2.92%
Year-to-Date
No recent news for Neogenomics Inc.

Today’s Trading

Previous close8.16
Today’s open8.24
Day’s range8.06 - 8.24
Volume88,097
Average volume (3 months)406,208
Market cap$635.6M
Dividend yield--
Data as of 3:19pm ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)-300.00%
Earnings growth (this year)+120.83%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+14.62%
P/E ratioNM
Price/Sales4.77
Price/Book2.95

Competitors

 Today’s
change
Today’s
% change
NTRANatera Inc+0.04+0.37%
FMIFoundation Medicine ...+0.34+1.42%
ACIUAC Immune Ltd+1.42+8.58%
PTIProteostasis Therape...+0.53+3.63%
Data as of 3:38pm ET, 09/27/2016

Financials

Next reporting dateOctober 19, 2016
EPS forecast (this quarter)$0.03
Annual revenue (last year)$99.8M
Annual profit (last year)-$2.5M
Net profit margin-2.54%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Vice President-
Operations
Mark Machulcz
Corporate headquarters
Fort Myers, Florida

Forecasts

Search for Jobs